A tiny implant may prevent a person from getting HIV for a year, reports the New York Times.
The implant: It’s a plastic tube the size of a matchstick that slowly releases an anti-HIV drug. It would be placed under the skin of the arm.
HIV prevention: Even if you don't have the virus, taking anti-HIV drugs daily can stop you from getting infected. Such "pre-exposure prophylaxis," or PrEP, is for people at high risk of getting the virus, according to the Centers for Disease Control and Prevention.
Set and forget: The idea behind the implant is that it would make PrEP easier. Because it would release an antiviral drug little by little over months, people would not have to remember to swallow pills. It’s based on a similar implant for birth control.
The evidence: The device is being developed by Merck, which carried out a three-month-long preliminary test in just 12 men. It contains an experimental, but long-acting, anti-HIV drug called islatravir. The company presented the prototype today at an HIV science conference in Mexico City.
Downsides: Without having to fear the HIV virus, people on PrEP drugs might end up getting other sexually transmitted diseases, like chlamydia and gonorrhea, more often. That was the finding of a study published this April on 4,375 gay and bisexual men in Australia.
How scientists want to make you young again
Research labs are pursuing technology to “reprogram” aging bodies back to youth.
Inside the billion-dollar meeting for the mega-rich who want to live forever
Hope, hype, and self-experimentation collided at an exclusive conference for ultra-rich investors who want to extend their lives past 100. I went along for the ride.
Human brain cells transplanted into baby rats’ brains grow and form connections
When lab-grown clumps of human neurons are transplanted into newborn rats, they grow with the animals. The research raises some tricky ethical questions.
The debate over whether aging is a disease rages on
In its latest catalogue of health conditions, the World Health Organization almost equated old age with disease. Then it backed off.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.